Henceforth, changes observed in the behavior of Luminal A cell lines treated with Hh inhibitors did not correlate with suppression of GLI1, PTCH1, and SMO transcripts, thus changes observed in tumor cell behavior are likely the result of off-target effects or non-canonical Hh signaling mechanisms [35]. The gene discussed is PTCH1; the disease is neoplasm.